bmiMD Reviews
Compounded GLP-1 weight-loss care, prescribed online and shipped cold-chain
Last updated: Sep 10, 2026
We may earn a commission from links on this page - it never affects our rankings (how we stay objective).
The bottom line
bmiMD is a credible, well-reviewed telehealth GLP-1 provider: its 4.4 Trustpilot average across 870 reviews is a real, high-volume track record, and the recurring praise for responsive support and carefully cold-packed shipping matches what you want from an online pharmacy handling temperature-sensitive medication. The honest caveats are that pricing is revealed at intake rather than published as a headline rate, and support runs through messaging.
If you want an established provider with a broad treatment menu and dependable delivery, bmiMD is worth a look - confirm the current plan pricing on its site before you commit.
bmiMD is a New York-based telehealth company offering compounded GLP-1 weight-loss treatment - semaglutide and tirzepatide, including microdose versions - prescribed online and shipped to your door in most US states. It carries a solid track record: 4.4 on Trustpilot across 870 reviews, where the recurring themes are responsive customer service and reliable, properly cold-packed delivery.
"Medication works as it should. Always delivered on time and packaged properly with cold packs," writes one recent reviewer; another reports going "from 238 to 213 in 3 weeks."
The flow is the standard cash-pay one - an online medical intake reviewed by a licensed provider, with a money-back guarantee if you're not approved. Two honest notes before the details: bmiMD publishes its current pricing at checkout rather than a single headline rate, so confirm the plan cost on its site, and support is handled through messaging rather than a phone line.
Key Features
- Compounded semaglutide and tirzepatide, plus microdose options
- Prescribed online by a licensed provider; ships to ~49 states
- Cold-chain delivery to your door
- 4.4 Trustpilot average across 870 reviews
- Money-back guarantee if you're not approved
Treatment Options
- Compounded semaglutide (GLP-1) injection
- Compounded tirzepatide (GLP-1 + GIP) injection
- Microdose versions of each
- Additional weight-related options (e.g. metformin, MIC + B12)
Pricing
bmiMD offers its compounded GLP-1 medications on subscription plans, with the current pricing shown on bmiMD's site at intake/checkout rather than as a single published headline rate. Because plan pricing can change, confirm the exact monthly cost on bmiMD before signing up.
(We only publish verified prices - we'll add bmiMD's figures here once confirmed.)
Pros
- Strong, high-volume Trustpilot record (4.4 across 870 reviews)
- Responsive customer service is the most consistent praise in reviews
- Reliable cold-chain shipping
- Broad treatment menu, including microdose options
- Money-back guarantee if you're not approved
Cons
- Pricing isn't shown as a single headline rate - you see it at intake
- Support is message-based rather than a phone line
Who It's Best For
- People who want an established provider with a broad GLP-1 menu
- Anyone who values responsive support and dependable delivery
bmiMD reviews on
TrustpilotAmazing Customer Service
“The customer service I have experienced w/ bmiMD is excellent. They always respond to messages within a timely matter. They always come up with a solution to any issues. I have nothing bad to say about them.”
Delaruth Wallace
US
So far...no side effects
“So far...no side effects! Just dropping weight that exercise and diet wouldn't. Have gone from 238 to 213 in 3 weeks. Shipping to my front door for easy delivery!”
MommaJ
US
Medication works as it should
“Medication works as it should. Always delivered on time and packaged properly with cold packs. Customer Service is very responsive.”
Anna
US
Excellent customer service
“Excellent customer service, quick shipping. The product I ordered is working wonderfully.”
Sandra Hansen
US
Final Verdict
bmiMD is a credible, well-reviewed telehealth GLP-1 provider: its 4.4 Trustpilot average across 870 reviews is a real, high-volume track record, and the recurring praise for responsive support and carefully cold-packed shipping matches what you want from an online pharmacy handling temperature-sensitive medication. The honest caveats are that pricing is revealed at intake rather than published as a headline rate, and support runs through messaging.
If you want an established provider with a broad treatment menu and dependable delivery, bmiMD is worth a look - confirm the current plan pricing on its site before you commit.
bmiMD Review: FAQs
Is bmiMD legit?
bmiMD is a New York-based telehealth company offering compounded GLP-1 weight-loss treatment - semaglutide and tirzepatide, including microdose versions - prescribed online and shipped to your door in most US states. It carries a solid track record: 4.4 on Trustpilot across 870 reviews, where the recurring themes are responsive customer service and reliable, properly cold-packed delivery. "Medication works as it should. Always delivered on time and packaged properly with cold packs," writes one recent reviewer; another reports going "from 238 to 213 in 3 weeks." The flow is the standard cash-pay one - an online medical intake reviewed by a licensed provider, with a money-back guarantee if you're not approved. Two honest notes before the details: bmiMD publishes its current pricing at checkout rather than a single headline rate, so confirm the plan cost on its site, and support is handled through messaging rather than a phone line.
How much does bmiMD cost?
bmiMD offers its compounded GLP-1 medications on subscription plans, with the current pricing shown on bmiMD's site at intake/checkout rather than as a single published headline rate. Because plan pricing can change, confirm the exact monthly cost on bmiMD before signing up. (We only publish verified prices - we'll add bmiMD's figures here once confirmed.)
What treatments does bmiMD offer?
bmiMD offers Compounded semaglutide (GLP-1) injection, Compounded tirzepatide (GLP-1 + GIP) injection, Microdose versions of each, Additional weight-related options (e.g. metformin, MIC + B12).
Who is bmiMD best for?
bmiMD is best for People who want an established provider with a broad GLP-1 menu; Anyone who values responsive support and dependable delivery.
Is bmiMD worth it?
bmiMD is a credible, well-reviewed telehealth GLP-1 provider: its 4.4 Trustpilot average across 870 reviews is a real, high-volume track record, and the recurring praise for responsive support and carefully cold-packed shipping matches what you want from an online pharmacy handling temperature-sensitive medication. The honest caveats are that pricing is revealed at intake rather than published as a headline rate, and support runs through messaging. If you want an established provider with a broad treatment menu and dependable delivery, bmiMD is worth a look - confirm the current plan pricing on its site before you commit.
Not sure if bmiMD is right for you?
Take our free quiz and get a personalized provider recommendation.
Find Your MatchRelated
Sources & methodology
We built this review of bmiMD from the provider'sown published pricing, plans and policies, cross-checked against regulatory and peer-reviewed medical references, and read alongside real customer feedback. Prices and plan details were verified against the provider's published information; we do not take providers' word for their own claims without checking.
Provider information
Pricing, plans, shipping and policies, checked against each provider's own site.
- bmiMD - pricing, plans & policies as published on its own site
Provider data checked September 2026
Customer & community feedback
Third-party signals shown on this page and in our full reviews: verified Trustpilot ratings, public Reddit discussions, and independent YouTube reviews. We report what these sources say - we never fold their ratings into our own scores.
Medical & regulatory references
- 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
- 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
- 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
- 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
- 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
- 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)
Last reviewed September 2026. We revisit comparisons when providers change their pricing or policies. This page is information only and is not medical advice - always consult a licensed clinician before starting treatment.